Concepedia

Publication | Open Access

CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence

DOIFull Paper Access

54

Citations

17

References

2014

Year

Fumiya Hongo, Natsuki Takaha, Masakatsu Oishi, Takashi Ueda, Terukazu Nakamura, Yasuyuki Naitoh, Yoshio Naya, Kazumi Kamoi, Koji Okihara, Tomoko Matsushima,
Urologic Oncology Seminars and Original Investigations

Abstract

CDK-based risk demonstrated is strongly associated with clinical outcome. CDK-based risk should be an accurate system for predicting recurrence and survival for planning follow-up.

References

YearCitations

Page 1